Detalles de la búsqueda
1.
Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials.
Lancet Oncol
; 25(1): 62-75, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012893
2.
TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.
Oncologist
; 29(1): 8-14, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37462445
3.
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
Br J Cancer
; 126(5): 797-803, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34949788
4.
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Br J Cancer
; 122(4): 555-563, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857723
5.
Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
Radiology
; 295(3): 572-580, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32228295
6.
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.
Genet Med
; 22(8): 1366-1373, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32341571
7.
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma.
Genet Med
; 22(4): 709-718, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31844177
8.
Distribution of KRAS G12C Somatic Mutations across Race, Sex, and Cancer Type.
N Engl J Med
; 384(2): 185-187, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33497555
9.
Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy.
Cancer Cell
; 42(1): 6-7, 2024 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157866
10.
Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 8: e2300439, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330262
11.
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 8: e2300371, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330261
12.
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study.
JACC CardioOncol
; 6(1): 71-79, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510282
13.
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.
J Immunother Cancer
; 12(3)2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448038
14.
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Clin Lymphoma Myeloma Leuk
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38714474
15.
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
J Thorac Oncol
; 2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38278303
16.
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
Nat Commun
; 14(1): 346, 2023 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36681680
17.
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
J Clin Oncol
; 41(21): 3712-3723, 2023 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192435
18.
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
J Natl Cancer Inst
; 115(12): 1605-1615, 2023 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563779
19.
Prevalence of pathogenic germline cancer risk variants in testicular cancer patients: Identifying high risk groups.
Urol Oncol
; 40(3): 113.e9-113.e15, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022142
20.
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma.
BJUI Compass
; 3(2): 169-172, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35224552